Articles related to PREVENTIVE MEDICINE

The FDA approved Moderna’s mFLUSIVA, the first mRNA influenza vaccine, for adults aged 50 and older. Availability is expected during the 2026–2027 respiratory virus season, with confirmatory evidence pending for adults 65 and older.

Three-year increases or sustained elevations in NT-proBNP were associated with greater cardiovascular and mortality risks among older adults without prior cardiovascular disease. Participants whose elevations resolved had risks resembling those who remained free of heart stress.

Emerging evidence suggests the sodium-to-potassium ratio may better reflect cardiovascular risk than sodium intake alone. Experts emphasized that increasing dietary potassium alongside sodium reduction may support blood pressure control, while acknowledging important safety considerations for select patient populations.

Discontinuing statins in adults 75 years and older without prior cardiovascular disease did not increase mortality or major cardiovascular events over three years in a randomized trial. LDL cholesterol rose substantially after discontinuation, and longer-term effects remain uncertain.

A mathematical modeling study estimated that somatic DNA mutations alone could limit median human life span to roughly 146 to 194 years. The findings add to ongoing research suggesting that aging reflects multiple interacting biological processes rather than a single mechanism.

Women presenting with acute myocardial infarction often report chest pain alongside additional symptoms such as dyspnea, nausea, fatigue, or jaw pain. Persistent diagnostic disparities continue to contribute to delays in recognition and treatment, particularly among younger women.